Y. Muramatsu, M. Tsujie, Y. Kohda, et al., “Early Detection of Cysteine Rich Protein 61 (CYR61, CCN1) in Urine Following Renal Ischemic Reperfusion Injury,” Kidney International, Vol. 62, No. 5, 2002, pp. 1601-1610. doi:10.1046/j.1523-1755.2002.00633.x

has been cited by the following article:

• TITLE: Biomarkers in Acute Kidney Injury

  AUTHORS: Cai-Mei Zheng, Min-Tser Liao, Mei-Yu Lin, Lan Lo, Chia-Chao Wu, Yung-Ho Hsu, Yuh-Feng Lin, Kuo-Cheng Lu

  KEYWORDS: Acute Kidney Injury; Critical Care Centers; Biomarkers; Renal Replacement Therapy

  JOURNAL NAME: Open Journal of Nephrology, Vol.3 No.1, March 28, 2013

  ABSTRACT: Acute kidney injury (AKI) is one of the popular topics of discussions due to increasing development of biomarkers recently. The disease progression and prognosis may be determined by these biomarkers detected in blood and urine specimens. Since acute kidney injury is associated with a broad spectrum of disease conditions, prevention and early detection of AKI becomes very important in those clinical settings. Early measurements of AKI biomarkers predict subsequent development of intrinsic AKI, dialysis requirement, duration of intensive care unit stay and finally affect mortality. We, here, discuss the acute kidney injury in different clinical situations and associated natures of biomarkers, which may help us guide to prevent and treat AKI more effectively.